AQSTAquestive TherapeuticsAQST info
$3.64info5.18%24h
Global rank15749
Market cap$242.97M
Change 7d0.53%
YTD Performance80.15%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Aquestive Therapeutics (AQST) Stock Overview

    Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

    AQST Stock Information

    Symbol
    AQST
    Address
    30 Technology DriveWarren, NJ 07059United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.aquestive.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    908 941 1900

    Aquestive Therapeutics (AQST) Price Chart

    -
    Value:-

    Aquestive Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.64
    N/A
    Market Cap
    $242.97M
    N/A
    Shares Outstanding
    66.77M
    N/A
    Employees
    130.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org